Sign in
4/A

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-034312

See Remarks sold 4,000 shares at an average $27.66 ($110,648)

  • See Remarks acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer See Remarks 2021-08-18 Option exercise +4,000 $4.30 $17,200 26,911 D
Michaelson Jennifer See Remarks 2021-08-18 Sale −2,863 $27.50 $78,733 24,048 D
Michaelson Jennifer See Remarks 2021-08-18 Sale −1,137 $28.07 $31,916 22,911 D
Derivatives
Michaelson Jennifer See Remarks 2021-08-18 Option exercise · Stock Option (Right to Buy) −4,000 225,978 D
Open-market sales · 4,000 sh · avg $27.66 · $110,648
Loading xslF345X03/doc4a.xml…